“Relaxin-2”的搜索结果，显示 161-170 项，共有 7661 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... II pump. A Study Of Clonal Hematopoiesis (CH) And Hematological Toxicity After ... For cycles 2-6: patient will visit the clinic once every 2 weeks for ...

2. 神经科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine the efficacy and acceptability of point of care EEG collected via the Muse 2 device for delirium ...

3. 神经科- 临床试验- 妙佑医疗国际

   Cohort 3 includes (1) CMVpp65 absent and (2) CMVpp65 present GBM.. Patients in all subcohorts except 1.11 and 1.12 currently have unresectable advanced or ...

4. 神经科- 临床试验- 妙佑医疗国际

   ... 2 participants will also undergo MRI scanning, comprehensive cognitive ... (2) Cohort 2 focuses on primary or secondary myelofibrosis (MF) displaying ...

5. 神经科- 临床试验- 妙佑医疗国际

   ... 2 participants will also undergo MRI scanning, comprehensive cognitive ... (2) Cohort 2 focuses on primary or secondary myelofibrosis (MF) displaying ...

6. 血液科- 临床试验- 妙佑医疗国际

   Cohort 3 includes (1) CMVpp65 absent and (2) CMVpp65 present GBM.. Patients in all subcohorts except 1.11 and 1.12 currently have unresectable advanced or ...

7. 神经科- 临床试验- 妙佑医疗国际

   Cohort 3 includes (1) CMVpp65 absent and (2) CMVpp65 present GBM.. Patients in all subcohorts except 1.11 and 1.12 currently have unresectable advanced or ...

8. 神经科- 临床试验- 妙佑医疗国际

   Cohort 3 includes (1) CMVpp65 absent and (2) CMVpp65 present GBM.. Patients in all subcohorts except 1.11 and 1.12 currently have unresectable advanced or ...

9. 神经科- 临床试验- 妙佑医疗国际

   ... 2 participants will also undergo MRI scanning, comprehensive cognitive ... (2) Cohort 2 focuses on primary or secondary myelofibrosis (MF) displaying ...

10. 神经科- 临床试验- 妙佑医疗国际

    Cohort 3 includes (1) CMVpp65 absent and (2) CMVpp65 present GBM.. Patients in all subcohorts except 1.11 and 1.12 currently have unresectable advanced or ...